Smith+Nephew Acquires CartiHeal for up to $330 Million

November 24, 2023

Smith+Nephew (S&N) has agreed to acquire Israeli medtech CartiHeal for up to $330 million, adding CartiHeal's Agili‑C implant to its Sports Medicine/knee repair portfolio. CartiHeal, founded in 2009 and headquartered in Kfar Saba, Israel, employs about 25 people and has FDA breakthrough-designated technology for osteochondral repair.

Buyers
Smith+Nephew
Targets
CartiHeal
Sellers
Existing shareholders (including aMoon, Elron, Peregrine Ventures, Access Medical Ventures, Pertec, Accelmed, JJDC)
Industry
Medical Devices
Location
Israel
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.